New Key Statistics Module, Z-Score and F-Score
NAS:ETON Key Ratios
| Market Cap $ M | 329.15 |
| Enterprise Value $ M | 305.65 |
| P/E(ttm) | -- |
| PE Ratio without NRI | -- |
| Forward PE Ratio | 28.03 |
| Price/Book | 20.55 |
| Price/Sales | 9.25 |
| Price/Free Cash Flow | 2,051.68 |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | 34.00 |
| EPS (TTM) $ | -0.22 |
| Beneish M-Score | -2.81 |
| 10-y EBITDA Growth Rate % | -- |
| 5-y EBITDA Growth Rate % | 60.40 |
| y-y EBITDA Growth Rate % | -242.50 |
| EV-to-EBIT | -50.78 |
| EV-to-EBITDA | -62.34 |
| PEG | -- |
| Shares Outstanding M | 25.84 |
| Net Margin (%) | -15.81 |
| Operating Margin % | -15.05 |
| Pre-tax Margin (%) | -15.30 |
| Quick Ratio | 1.41 |
| Current Ratio | 1.51 |
| ROA % (ttm) | -16.95 |
| ROE % (ttm) | -35.45 |
| ROIC % (ttm) | -55.01 |
| Dividend Yield % | -- |
| Altman Z-Score | 6.35 |
ETON Number of Guru Trades
ETON Volume of Guru Trades
Gurus Latest Trades with NAS:ETON
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:ETON is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Eton Pharmaceuticals Inc Insider Transactions
No Available Data
News about NAS:ETON
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers